These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10958645)

  • 1. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
    Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
    Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia.
    Xu CF; Talmud P; Schuster H; Houlston R; Miller G; Humphries S
    Clin Genet; 1994 Dec; 46(6):385-97. PubMed ID: 7889654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.
    Groenendijk M; De Bruin TW; Dallinga-Thie GM
    Atherosclerosis; 2001 Oct; 158(2):369-76. PubMed ID: 11583715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
    Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia.
    Groenendijk M; Cantor RM; Funke H; Dallinga-Thie GM
    Eur J Clin Invest; 2001 Oct; 31(10):852-9. PubMed ID: 11737222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
    Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
    Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
    Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
    Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
    J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).
    Cavallo MG; Montali A; Monetini L; Valente L; Mariani P; Bifolco M; Sirinian MI; Antonini TM; Fioretti F; Campagna F; Verna R; Arca M
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):262-9. PubMed ID: 16054550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
    Aouizerat BE; Allayee H; Cantor RM; Davis RC; Lanning CD; Wen PZ; Dallinga-Thie GM; de Bruin TW; Rotter JI; Lusis AJ
    Am J Hum Genet; 1999 Aug; 65(2):397-412. PubMed ID: 10417282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.
    Groenendijk M; Cantor RM; De Bruin TW; Dallinga-Thie GM
    J Lipid Res; 2001 Feb; 42(2):188-94. PubMed ID: 11181747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.